SCHEDULE 13G/AFiled Feb 12, 7:00 PM ET
Terns Pharmaceuticals, Inc. SCHEDULE 13G/A
Vivo Opportunity Fund Holdings, L.P.Summary not available
This filing does not have a generated research summary. You can still open the original filing and its exhibits.